Complying with healthcare standards and legal regimes in Asia can be a major hurdle. Indeed, recent years have seen a number of cases where corporations have suffered heavy fines for various breaches, prominent among them the fining of a multinational British pharma company for 3 billion yuan (US$460m) in China on counts of corruption. Outside of this case and across the region, governments are stepping up regulation to monitor the healthcare industry. Baker McKenzie’s Vivian Wu and Ben McLaughlin provide tips and tactics to comply with healthcare laws, mitigate risks, and avoid litigation.
PRIORITIZE COMPLIANCE WITH ANTI-BRIBERY AND CORRUPTION LAWS
Back_to_top_arrow.svg
Healthcare STEPS FOR SUCCESS: Upping the dosage of compliance and due diligence
Hamburger_Icon.svgCross.svg
BM_logo_colour_retina_x2
FOREWORD
Red_Down_Arrow.svgTop_Red_Arrow.svg
FEATURES
CONCLUSION
CONTACTS
Share icon
Red_Down_Arrow.svgTop_Red_Arrow.svg
Top_Red_Arrow.svg
SECTORS
Linkedin share iconTwitter share icone-mail share icon
RETURN TO BAKERMCKENZIE.COM
ReturnArrow.svg
Visit Business Complexities Survey